Home > Boards > US Listed > Biotechs > MediciNova, Inc. (MNOV)

EB, Yes, possibly a pretty good sale to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
someconcerns Member Profile
 
Followed By 30
Posts 2,502
Boards Moderated 1
Alias Born 04/01/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:07:04 PM
MediciNova to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:15:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:05:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:03:53 PM
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS GlobeNewswire Inc. - 6/5/2019 7:00:00 PM
MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/15/2019 7:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:42:49 PM
MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the ... GlobeNewswire Inc. - 5/7/2019 7:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/1/2019 5:29:15 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 5:10:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/26/2019 6:22:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 4:33:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/25/2019 4:20:32 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma GlobeNewswire Inc. - 4/23/2019 7:00:00 PM
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS GlobeNewswire Inc. - 4/15/2019 7:00:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholes... GlobeNewswire Inc. - 4/3/2019 7:00:00 PM
MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS GlobeNewswire Inc. - 4/1/2019 7:00:00 PM
MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multi... GlobeNewswire Inc. - 3/24/2019 7:00:00 PM
MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan GlobeNewswire Inc. - 3/5/2019 6:51:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 6:12:08 AM
MediciNova Announces the Publication of Results of the Animal Model Study of MN‑166 (ibudilast) in Glioblastoma in Scientif... GlobeNewswire Inc. - 2/28/2019 6:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2019 6:44:27 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/13/2019 5:06:26 PM
someconcerns   Tuesday, 08/18/15 04:41:31 PM
Re: Ebuilder post# 348
Post # of 392 
EB, Yes, possibly a pretty good sale to happen on MNOV shs. The ad should be in tomorrow's paper and we can all run and line up outside the doors of the store.

Probably, depending on how many shares, we'll be back to yesterday's level in a couple weeks or less. Will be interesting if the shares will be offered only here or also in Japan and which insiders may buy.

All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist